Dataset Information


Development of a Combined Genetic Engineering Vaccine for Porcine Circovirus Type 2 and Mycoplasma Hyopneumoniae by a Baculovirus Expression System.

ABSTRACT: Mycoplasma hyopneumoniae (Mhp) and porcine circovirus type 2 (PCV2) are the main pathogens for mycoplasmal pneumonia of swine (MPS) and post-weaning multisystemic wasting syndrome (PMWS), respectively. Infection by these pathogens often happens together and causes great economic losses. In this study, a kind of recombinant baculovirus that can display P97R1P46P42 chimeric protein of Mhp and the capsid (Cap) protein of PCV2 was developed, and the protein location was identified. Another recombinant baculovirus was constructed without tag proteins (EGFP, mCherry) and was used to evaluate the immune effect in experiments with BALB/c mice and domestic piglets. Antigen proteins P97R1P46P42 and Cap were expressed successfully; both were anchored on the plasma membrane of cells and the viral envelope. It should be emphasized that in piglet immunization, the recombinant baculovirus vaccine achieved similar immunological effects as the mixed commercial vaccine. Both the piglet and mouse experiments showed that the recombinant baculovirus was able to induce humoral and cellular responses effectively. The results of this study indicate that this recombinant baculovirus is a potential candidate for the further development of more effective combined genetic engineering vaccines against MPS and PMWS. This experiment also provides ideas for vaccine development for other concomitant diseases using the baculovirus expression system.

PROVIDER: S-EPMC6770761 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC7493066 | BioStudies
| S-EPMC7487469 | BioStudies
| S-EPMC2919472 | BioStudies
| S-EPMC9318870 | BioStudies
| S-EPMC4466504 | BioStudies
| S-EPMC8624748 | BioStudies
| S-EPMC3539982 | BioStudies
| S-EPMC7006081 | BioStudies
| S-EPMC6415871 | BioStudies
| S-EPMC4746120 | BioStudies